Product image of Metilprednisolona Reig Jofre (Methylprednisolone Aceponate) supplied by GNH India

Metilprednisolona Reig Jofre

Active Ingredient:
Methylprednisolone Aceponate
Origin:
EU

Metilprednisolona Reig Jofre (Methylprednisolone Aceponate)

Methylprednisolone aceponate, the active ingredient in Metilprednisolona Reig Jofre, is a glucocorticoid presented as a topical formulation for topical use. It is employed to reduce inflammation and relieve symptoms in various inflammatory skin disorders such as psoriasis, eczema, atopic dermatitis, and contact dermatitis.

GNH India supplies Metilprednisolona Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality‑assurance processes and regulatory compliance across EU and other markets. The company provides reliable logistics and documentation support for cross‑border shipments.

Manufacturer / TM Owner

Laboratorio Reig Jofre, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylprednisolone aceponate is a topical glucocorticoid used to treat inflammatory skin conditions.

  • Psoriasis: reduces scaling, redness and itching of plaque lesions.
  • Eczema: diminishes inflammation and pruritus associated with acute flare‑ups.
  • Atopic dermatitis: controls chronic inflammation and improves skin barrier function.
  • Contact dermatitis: alleviates irritation caused by allergens or irritants.
  • Other inflammatory skin disorders: provides anti‑inflammatory relief in conditions such as seborrheic dermatitis.

How It Works

  • Methylprednisolone aceponate penetrates the epidermis and binds to intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it modulates gene transcription, suppressing pro‑inflammatory cytokines, inhibiting leukocyte migration, and reducing fibroblast proliferation, resulting in localized anti‑inflammatory and immunosuppressive effects in the skin.

Side Effects

Topical methylprednisolone aceponate may cause local and systemic reactions.

Common Side Effects

  • Burning or stinging sensation at the application site.
  • Skin dryness or peeling.
  • Pruritus or mild irritation.
  • Folliculitis or acneiform eruptions.
  • Telangiectasia (visible small blood vessels).

Serious or Rare Side Effects

  • Skin atrophy or thinning with prolonged use.
  • Secondary bacterial, fungal or viral infection.
  • Systemic adrenal suppression when large areas are treated.
  • Hypersensitivity reactions such as rash or urticaria.
  • Delayed wound healing or ulceration.

Precautions & Warnings

Use methylprednisolone aceponate according to clinical guidelines and monitor for adverse reactions.

  • Assess severity: reserve for moderate to severe inflammatory dermatoses when lower‑potency steroids are insufficient.
  • Limit duration: avoid continuous use beyond recommended periods to reduce risk of skin atrophy.
  • Avoid occlusion: do not cover treated area with airtight dressings unless directed by a clinician.
  • Monitor for infection: discontinue if signs of bacterial, fungal or viral infection appear.
  • Pregnancy and lactation: safety not established; use only if potential benefit justifies the risk.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Topical methylprednisolone aceponate can interact with other medications applied to the skin or absorbed systemically.

Major Interactions (Avoid)

  • Systemic corticosteroids: may increase systemic glucocorticoid effects.
  • CYP450 enzyme inducers (e.g., rifampicin): may reduce local potency.
  • Antifungal topicals (e.g., ketoconazole): may enhance percutaneous absorption.

Moderate Interactions (Monitor Closely)

  • Topical NSAIDs: may increase local irritation.
  • Retinoids: can potentiate skin irritation and dryness.
  • Antibiotic ointments: monitor for additive irritation or allergic reactions.

Frequently Asked Questions

Metilprednisolona Reig Jofre contains methylprednisolone aceponate, a topical glucocorticoid indicated for inflammatory skin disorders such as psoriasis, eczema, atopic dermatitis, contact dermatitis and other similar conditions where reduction of redness, swelling and itching is required.

Methylprednisolone aceponate penetrates the epidermis and binds to intracellular glucocorticoid receptors. This complex alters gene transcription, suppressing pro‑inflammatory cytokines, reducing leukocyte migration and inhibiting fibroblast activity, which together provide localized anti‑inflammatory and immunosuppressive effects.

The appropriate dose and frequency are determined by the prescribing clinician based on the severity of the skin condition, the area to be treated and patient‑specific factors. The product is applied as a thin layer to the affected skin as directed by a healthcare professional.

Safety data for methylprednisolone aceponate in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methylprednisolone aceponate is a mid‑ to high‑potency topical glucocorticoid, offering stronger anti‑inflammatory activity than low‑potency agents such as hydrocortisone, but with a lower risk of systemic effects compared with very high‑potency steroids like clobetasol. Choice of therapy depends on disease severity and treatment area.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The medication is applied topically to clean, dry skin. A thin layer should be spread over the affected area, gently massaged until absorbed. Frequency and duration of application are prescribed by a healthcare professional, typically ranging from once to twice daily for a limited period.

Serious risks include skin atrophy, telangiectasia, secondary infections, systemic adrenal suppression when large surface areas are treated, and hypersensitivity reactions such as rash or urticaria. Patients should be monitored for these effects, especially with prolonged or extensive use.

The product should be avoided in individuals with known hypersensitivity to methylprednisolone aceponate or any excipients, in untreated fungal, bacterial or viral skin infections, and in patients where a lower‑potency steroid would be sufficient. Caution is also advised for children and the elderly.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone Aceponate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT